NovaBay Pharmaceuticals, Inc. (NBY) Stock Price

NBYStock
$0.9888.67%52W
Market Cap
P/E
PEG Ratio
Div yield0.00%
Beta0.02

NBY Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-55.29%
Price vs S&P 500 (4W)-17.34%
VGM Score23.81
Indicated Dividend Yield (Annual)0.00%

NBY Analyst Recommendations

Jun 2025
Jul 2025
Aug 2025
Oct 2025
4.00
4.00
4.00
4.00

Industry Peers — Pharmaceuticals(570)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
NBYNovaBay Pharmaceuticals, Inc.
DDF$0.98
LLYEli Lilly & Co.DBC$1174.61
JNJJohnson & JohnsonDCB$268.04
ABBVABBVIE INC.DCB$255.48
MRKMerck & Co., Inc.DCB$148.35
NVSNovartis AGCCC$153.81
AZNAstraZeneca PLCCBC$162.70
NVONovo-Nordisk A/SBCC$45.61
ABTAbbott LaboratoriesCCC$112.47
PFEPfizer Inc.CDB$27.96
VRTXVertex Pharmaceuticals IncDCB$541.69

About NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals develops and commercializes clinically-proven eyecare, wound care, and skin care products. Its flagship product, Avenova Antimicrobial Lid and Lash Solution, is marketed directly to consumers online and prescribed by eyecare professionals for blepharitis and dry-eye disease. The product features broad-spectrum antimicrobial properties to remove microorganisms and debris from the eye area.